MedTrace Logo

Evaluation of Immersive Audiovisual Distraction Impact on Peroperative Opioid Consumption.

NCT04238572 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-08-03

No results posted yet for this study

Summary

This study evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption for outpatient procedures with Remifentanil added to local anesthesia.

Half of patients will receive an audiovisual distraction device while the other half not.

Conditions

  • Surgical Procedure, Unspecified
  • Analgesia
  • Outpatient

Interventions

DEVICE

Audiovisual distraction device

Evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption

DEVICE

Analgesia nociception index

ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Clément Buléon, MD · Caen UH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-19
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04238572 on ClinicalTrials.gov